KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares IssuedShares Repurchased
Ratios

Vertex Pharmaceuticals (VRTX) Shares Issued (2016 - 2025)

Historic Shares Issued for Vertex Pharmaceuticals (VRTX) over the last 17 years, with Q4 2025 value amounting to $54.0 million.

  • Vertex Pharmaceuticals' Shares Issued rose 5743.44% to $54.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $127.7 million, marking a year-over-year increase of 1143.11%. This contributed to the annual value of $127.7 million for FY2025, which is 1143.11% up from last year.
  • Vertex Pharmaceuticals' Shares Issued amounted to $54.0 million in Q4 2025, which was up 5743.44% from $7.9 million recorded in Q3 2025.
  • Vertex Pharmaceuticals' Shares Issued's 5-year high stood at $64.4 million during Q2 2022, with a 5-year trough of $7.9 million in Q3 2025.
  • In the last 5 years, Vertex Pharmaceuticals' Shares Issued had a median value of $34.5 million in 2021 and averaged $33.3 million.
  • Its Shares Issued has fluctuated over the past 5 years, first crashed by 8040.13% in 2021, then surged by 16521.74% in 2022.
  • Vertex Pharmaceuticals' Shares Issued (Quarter) stood at $34.7 million in 2021, then soared by 48.7% to $51.6 million in 2022, then dropped by 10.08% to $46.4 million in 2023, then dropped by 26.08% to $34.3 million in 2024, then surged by 57.43% to $54.0 million in 2025.
  • Its Shares Issued was $54.0 million in Q4 2025, compared to $7.9 million in Q3 2025 and $49.1 million in Q2 2025.